Consolidated Statements of Operations - USD ($)	12 Months Ended
	Dec. 31, 2014	Dec. 31, 2013
Revenue
Product sales	$ 1,045,080	$ 652,792
Cost of product sales	440,668	272,736
Gross profit from product sales	604,412	380,056
Other Revenue
Retained royalties	27,782	37,007
Other income	90,776	82,069
Total other revenue	118,558	119,076
Operating expenses
Selling expenses	213,419	159,245
Personnel and consulting expenses	1,368,299	1,100,041
General and administrative expenses	1,371,035	1,760,585
Total operating expenses	2,952,753	3,019,871
Operating loss	(2,229,783)	(2,520,739)
Other expense (income)
Interest expense	964,070	$ 209,953
Interest expense - accelerated upon conversion of OID notes	35,109
Loss on conversion of notes	63,867
Loss on settlement of note and warrant	132,301
Unrealized gain on derivative instruments	(14,231)	$ (58,538)
Total other expense	1,181,116	151,415
Loss before income taxes	$ (3,410,899)	$ (2,672,154)
Provision (benefit) for income taxes
Net loss	$ (3,410,899)	$ (2,672,154)
Basic and diluted loss per share	$ (0.15)	$ (0.16)
Basic and diluted weighted average number of common shares outstanding:	23,513,870	16,977,027